|
US4812462A
(en)
|
1986-04-01 |
1989-03-14 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
|
|
US4816463A
(en)
|
1986-04-01 |
1989-03-28 |
Warner-Lambert Company |
Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
|
|
WO1992005784A1
(en)
|
1990-10-02 |
1992-04-16 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
|
|
MXPA05000945A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
|
|
US20060100233A1
(en)
|
2002-07-25 |
2006-05-11 |
Manuela Villa |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
GB0312609D0
(en)
|
2003-06-02 |
2003-07-09 |
Astrazeneca Ab |
Novel compounds
|
|
FR2857363B1
(fr)
|
2003-07-10 |
2007-09-07 |
Aventis Pharma Sa |
4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
|
|
AR045037A1
(es)
|
2003-07-10 |
2005-10-12 |
Aventis Pharma Sa |
Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
|
|
DE602005022320D1
(de)
|
2004-08-23 |
2010-08-26 |
Merck Sharp & Dohme |
Kondensierte triazolderivate als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
|
|
EP1844003A4
(en)
|
2005-01-27 |
2010-09-22 |
Astrazeneca Ab |
NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
|
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
WO2006110516A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
Acylhydrazide p2x7 antagonists and uses thereof
|
|
US7943617B2
(en)
|
2006-11-27 |
2011-05-17 |
Bristol-Myers Squibb Company |
Heterobicyclic compounds useful as kinase inhibitors
|
|
FR2915197B1
(fr)
|
2007-04-18 |
2009-06-12 |
Sanofi Aventis Sa |
Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
|
|
US8349858B2
(en)
|
2007-06-21 |
2013-01-08 |
Merck Sharp & Dohme |
Polycyclic guanine derivatives and use thereof
|
|
EP2185560A4
(en)
|
2007-08-10 |
2011-10-05 |
Lundbeck & Co As H |
HETEROARYLAMIDE ANALOGS
|
|
FR2921342B1
(fr)
|
2007-09-20 |
2010-03-12 |
Airbus France |
Carenage aerodynamique arriere inferieur pour dispositif d'accrochage d'un moteur d'aeronef
|
|
EP2090576A1
(en)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
|
|
JP5369173B2
(ja)
|
2008-04-22 |
2013-12-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キノリン若しくはイソキノリン置換p2x7アンタゴニスト
|
|
US8309578B2
(en)
|
2008-11-25 |
2012-11-13 |
Nerviano Medical Sciences S.R.L. |
Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
|
|
WO2010066629A2
(en)
|
2008-12-09 |
2010-06-17 |
F. Hoffmann-La Roche Ag |
Novel azaindoles
|
|
WO2010125102A1
(en)
|
2009-04-29 |
2010-11-04 |
Glaxo Group Limited |
5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
|
|
GB0907515D0
(en)
|
2009-04-30 |
2009-06-10 |
Glaxo Group Ltd |
Compounds
|
|
US8871760B2
(en)
|
2009-09-21 |
2014-10-28 |
Roche Palo Alto Llc |
[1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
|
|
EP2491031B1
(en)
|
2009-10-23 |
2013-08-07 |
Janssen Pharmaceutica N.V. |
Fused heterocyclic compounds as orexin receptor modulators
|
|
WO2011103715A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Task channel antagonists
|
|
CA2793313C
(en)
|
2010-04-02 |
2018-01-23 |
Euroscreen Sa |
Nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
|
|
US20110252717A1
(en)
|
2010-04-16 |
2011-10-20 |
Graf Fernandez Rodrigo |
Foldable structures for a construction
|
|
US20130196986A1
(en)
|
2010-09-21 |
2013-08-01 |
Marc Labroli |
Triazolopyrazinones as p2x7 receptor antagonists
|
|
KR20130140020A
(ko)
|
2010-10-22 |
2013-12-23 |
얀센 파마슈티카 엔.브이. |
모노아실글리세롤 리파아제 억제제로서의 아미노-피롤리딘-아제티딘 다이아미드
|
|
JP2013540159A
(ja)
*
|
2010-10-22 |
2013-10-31 |
ヤンセン ファーマシューティカ エヌ.ベー. |
モノアシルグリセロールリパーゼ阻害剤としてのピペリジン−4−イル−アゼチジンジアミド
|
|
WO2012145581A1
(en)
|
2011-04-20 |
2012-10-26 |
Janssen Pharmaceutica Nv |
Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
|
|
IN2014CN02806A
(cg-RX-API-DMAC7.html)
*
|
2011-10-14 |
2015-07-03 |
Bristol Myers Squibb Co |
|
|
US9273947B2
(en)
|
2012-02-07 |
2016-03-01 |
Lg Innotek Co., Ltd. |
Sensing magnet apparatus for motor
|
|
US9056874B2
(en)
|
2012-05-04 |
2015-06-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CA2874621A1
(en)
|
2012-05-22 |
2013-11-28 |
Genentech, Inc. |
N-substituted benzamides and their use in the treatment of pain
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
JO3459B1
(ar)
|
2012-09-09 |
2020-07-05 |
H Lundbeck As |
تركيبات صيدلانية لعلاج مرض الزهايمر
|
|
BR112015008480A2
(pt)
|
2012-10-15 |
2017-07-04 |
Epizyme Inc |
compostos de benzeno substituído
|
|
MY189505A
(en)
|
2012-10-16 |
2022-02-16 |
Janssen Pharmaceutica Nv |
Methylene linked quinolinyl modulators of roryt
|
|
CA2888816A1
(en)
|
2012-11-01 |
2014-05-08 |
Incyte Corporation |
Tricyclic fused thiophene derivatives as jak inhibitors
|
|
US9796729B2
(en)
|
2012-11-23 |
2017-10-24 |
Glaxosmithkline Llc |
Compounds as diacylglycerol acyltransferase inhibitors
|
|
CA2895808A1
(en)
|
2012-12-21 |
2014-06-26 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
ME03000B
(me)
|
2012-12-21 |
2018-10-20 |
Plexxikon Inc |
Jedinjenja i metode modulacije kinaze i povezane indikacije
|
|
CN105188371A
(zh)
|
2013-02-08 |
2015-12-23 |
西建阿维拉米斯研究公司 |
Erk抑制剂及其用途
|
|
NO335177B1
(no)
|
2013-03-06 |
2014-10-13 |
Cambi Technology As |
Fremgangsmåte og anordning for termisk biologisk nedbryting og avvanning av biomasse
|
|
JO3516B1
(ar)
|
2013-03-06 |
2020-07-05 |
Janssen Pharmaceutica Nv |
مُعدِّلات بنزإيميدازول-2-يل بيريميدين لمستقبل الهستامين h4
|
|
CN105189461B
(zh)
|
2013-03-14 |
2018-05-15 |
葛兰素史克知识产权第二有限公司 |
2,3-二取代的1-酰基-4-氨基-1,2,3,4-四氢喹啉衍生物和它们作为溴结构域抑制剂的用途
|
|
JP6603649B2
(ja)
|
2013-03-14 |
2019-11-06 |
キュラデブ ファーマ プライベート リミテッド |
キヌレニン経路の阻害剤
|
|
ES2689526T3
(es)
|
2013-03-14 |
2018-11-14 |
Janssen Pharmaceutica Nv |
Moduladores de P2X7
|
|
JP6294953B2
(ja)
|
2013-03-14 |
2018-03-14 |
ヤンセン ファーマシューティカ エヌ.ベー. |
P2x7調節物質
|
|
CA2902174A1
(en)
|
2013-03-14 |
2014-10-02 |
Newlink Genetics Corporation |
Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
|
|
EA029052B1
(ru)
|
2013-03-14 |
2018-02-28 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
JO3509B1
(ar)
|
2013-03-14 |
2020-07-05 |
Janssen Pharmaceutica Nv |
معدلات p2x7
|
|
JO3383B1
(ar)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
مثبطات cdc7
|
|
TWI599567B
(zh)
|
2013-03-14 |
2017-09-21 |
健生藥品公司 |
P2x7調節劑
|
|
ES2721018T3
(es)
|
2013-03-29 |
2019-07-26 |
Ogeda S A |
N-Acil-(3-sustituido)-(8-metil)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas como antagonistas selectivos del receptor NK-3, composición farmacéutica, métodos para su uso en trastornos mediados por el receptor de NK-3
|
|
WO2015025026A1
(en)
|
2013-08-22 |
2015-02-26 |
F. Hoffmann-La Roche Ag |
Alkynyl alcohols and methods of use
|
|
JP6715239B2
(ja)
|
2014-09-11 |
2020-07-01 |
ヤンセン ファーマシューティカ エヌ.ベー. |
置換2−アザ二環式化合物及びオレキシン受容体調節因子としてのその使用
|
|
AU2015315693B2
(en)
|
2014-09-12 |
2020-01-16 |
Janssen Pharmaceutica Nv |
P2X7 modulating n-acyl-triazolopyrazines
|
|
WO2016039977A1
(en)
|
2014-09-12 |
2016-03-17 |
Janssen Pharmaceutica Nv |
P2x7 modulators
|
|
US10106556B2
(en)
*
|
2015-03-30 |
2018-10-23 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2017087858A1
(en)
|
2015-11-20 |
2017-05-26 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
|
JP2020506903A
(ja)
*
|
2017-01-23 |
2020-03-05 |
ファイザー・インク |
Magl阻害薬としての複素環式スピロ化合物
|
|
JP7413368B2
(ja)
|
2018-09-28 |
2024-01-15 |
ヤンセン ファーマシューティカ エヌ.ベー. |
モノアシルグリセロールリパーゼ調節因子
|
|
MA53721A
(fr)
|
2018-09-28 |
2021-09-15 |
Janssen Pharmaceutica Nv |
Modulateurs de la monoacylglycérol lipase
|
|
CN112272670B
(zh)
|
2019-04-16 |
2023-12-12 |
上海翰森生物医药科技有限公司 |
含二并环类衍生物抑制剂、其制备方法和应用
|
|
CA3156100A1
(en)
|
2019-09-30 |
2021-04-08 |
Janssen Pharmaceutica Nv |
Radiolabelled mgl pet ligands
|
|
CA3176946A1
(en)
|
2020-03-26 |
2021-09-30 |
Janssen Pharmaceutica Nv |
Monoacylglycerol lipase modulators
|